Breast cancer drug Herceptin 'prolongs life'

Researchers from the Royal Marsden Hospital in London have confirmed that giving Herceptin to women with certain types of breast cancer does prolong their lives. The study, published in The Lancet, followed women for two years after treatment and found a 2.7 per cent ...

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Already a subscriber? Sign into your account here